// App-Quantinova.ai

BSH19‐PO‐042 : Oral prednisolone therapy switches pro‐inflammatory intermediate monocytes in treatment‐naïve immune thrombocytopenia patients to an anti‐inflammatory phenotype

Researchers

Presenter

  • E. Williams

Principal Investigators

  • M. Stimpson

  • L. Schewitz-Bowers

  • P. Lait

  • L. Jones

  • R. Lee

  • C. Bradbury

Medical Centers

  • University of Bristol, Bristol, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Immune thrombocytopenia

Biomarkers

  • Peripheral blood mononuclear cell

  • Cluster of Differentiation 14

  • Cluster of Differentiation 163

  • Cluster of Differentiation 206

  • Fc gamma RIIIa

Drug/Treatment

  • Glucocorticoid

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Prednisolone

Outcome

  • N/A

Study Design

  • Adaptive

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved